The results showed that the expression levels of PD‐L1 and HLA‐G in advanced NSCLC tumors were higher than those in early‐stage tumors, with no detectable expression observed in the paired normal tissue adjacent to the tumor (NAT) (Figure 1A–E). This evidence concerns the gene BRD2 and non-small cell lung carcinoma.